Summary
The product Drostargos 200 mg/ml, manufactured by Driada Medical, underwent independent analysis to verify its composition and potency. The sample, identified by batch number 064033, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Drostanolone Enanthate with a measured concentration of 198.73 mg/ml, closely matching the label claim of 200 mg/ml. This represents a 0.64% variance, indicating precise dosing as per the product specification.
The testing process was initiated on 13 December 2021, with the sample received on 14 December 2021, and the analysis completed on 16 December 2021. The sample was submitted and funded by Driada Medical, warranting careful scrutiny of the results. It is noted that the sample was retested twice for verification. This report is intended for educational and harm reduction purposes, helping users make informed decisions about the accuracy of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: Drostargos 200 mg/ml
- Active Ingredient: Drostanolone Enanthate
- Batch Number: 064033
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #15086
- Testing Ordered: 13 December 2021
- Sample Received: 14 December 2021
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 198.73 mg/ml
- Accuracy: 99.36% (0.64% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/15086_AHL9VV2RQTMR
- Originally Published: https://thinksteroids.com/community/posts/2910574/
Evaluation of Manufacturer-Funded Testing
As this analysis was both submitted and paid for by Driada Medical, the findings should be interpreted with care. Manufacturer-funded testing raises questions about potential bias, such as the selection of optimal batches for analysis. However, Janoshik Analytical is recognized for its transparency and history of reliable testing, lending credibility to the results. Additionally, the retesting of this sample adds a layer of verification, supporting the accuracy of the reported findings.
Independent testing by a third party would further validate these results, enhancing consumer confidence in the product’s quality and consistency.
Conclusion
The analysis of Drostargos 200 mg/ml confirms that the product is accurately dosed, with only a minimal variance of 0.64% below the label claim. These findings highlight the importance of laboratory testing in ensuring the quality and reliability of anabolic steroid products. This report provides valuable insights for harm reduction and educational purposes, helping individuals make informed decisions regarding the use of these substances.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
